Phase 2 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 40 years of age or older
• People who have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring disease
• People with IPF who are either currently taking an approved anti-scarring medication at a steady, unchanged dose, or who are not currently taking any standard treatment for IPF
• People whose lungs are still functioning at 45% or more of the expected normal level, based on a breathing test called FVC
• People whose lungs are still able to transfer oxygen into the blood at 25% or more of the expected normal level, based on a test called DLCO (confirm with trial site)

Who may not be able to join:

• People who have a different type of lung scarring disease other than IPF
• People whose chest scans show more emphysema (air trapping damage) than lung scarring
• People who are currently experiencing a sudden worsening of their IPF symptoms
• People who currently have a lower airway or lung infection that requires treatment
• People who have recently had a heart attack, unstable chest pain, or a heart procedure such as a stent or bypass surgery
• People who have heart failure
• People who have previously had an organ transplant, or for whom a lung transplant is being considered in the near future

Important: Always verify eligibility with the trial site directly before applying.